169 related articles for article (PubMed ID: 9645210)
1. [Treatment of stage IIIB loco-regionally advanced non-small-cell bronchial carcinomas with radiation and interferon-beta. Preliminary results of a phase II study].
Bund J; Eberhardt K; Hartmann W; Habermalz HJ
Strahlenther Onkol; 1998 Jun; 174(6):300-5. PubMed ID: 9645210
[TBL] [Abstract][Full Text] [Related]
2. A phase III comparison of radiation therapy with or without recombinant beta-interferon for poor-risk patients with locally advanced non-small-cell lung cancer (RTOG 93-04).
Bradley JD; Scott CB; Paris KJ; Demas WF; Machtay M; Komaki R; Movsas B; Rubin P; Sause WT
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1173-9. PubMed ID: 11955727
[TBL] [Abstract][Full Text] [Related]
3. [The results of the endoluminal high-dose-rate irradiation of central non-small cell bronchial carcinomas].
Schraube P; Fritz P; Becker HD; Wannenmacher M
Strahlenther Onkol; 1993 Apr; 169(4):228-34. PubMed ID: 8387698
[TBL] [Abstract][Full Text] [Related]
4. Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Qian H; Wang LJ; Yang HJ; Fu XL; Wu KL; Zang Z; Zhao S
Radiother Oncol; 2004 May; 71(2):157-62. PubMed ID: 15110448
[TBL] [Abstract][Full Text] [Related]
5. [Bronchial cancer: radiation therapy].
Heilmann HP
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():95-8. PubMed ID: 1983685
[TBL] [Abstract][Full Text] [Related]
6. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer.
Sause WT; Scott C; Taylor S; Johnson D; Livingston R; Komaki R; Emami B; Curran WJ; Byhardt RW; Turrisi AT
J Natl Cancer Inst; 1995 Feb; 87(3):198-205. PubMed ID: 7707407
[TBL] [Abstract][Full Text] [Related]
7. [Treatment outcome of locally advanced stage IIIA/B lung cancer].
Cicenas S; Zaliene A; Atkocius V
Medicina (Kaunas); 2009; 45(6):452-9. PubMed ID: 19605965
[TBL] [Abstract][Full Text] [Related]
8. DART-bid for loco-regionally advanced NSCLC : Summary of acute and late toxicity with long-term follow-up; experiences with pulmonary dose constraints.
Wurstbauer K; Zehentmayr F; Deutschmann H; Dagn K; Exeli AK; Kopp P; Porsch P; Maurer B; Studnicka M; Sedlmayer F
Strahlenther Onkol; 2017 Apr; 193(4):315-323. PubMed ID: 28116446
[TBL] [Abstract][Full Text] [Related]
9. [Optimization of combined radiotherapy and chemotherapy in treatment of non-small cell lung carcinoma].
Bretel JJ; Arriagada R; Le Chevalier T; Baldeyrou P; Grunenwald D; Le Péchoux C; Pellae-Cosset B; Ruffié P
Cancer Radiother; 1997; 1(2):148-53. PubMed ID: 9273186
[TBL] [Abstract][Full Text] [Related]
10. Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer.
Ajlouni M; Chapman R; Kim JH
Cancer J Sci Am; 1996; 2(6):314-20. PubMed ID: 9166551
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancer.
Pujol JL; Lafontaine T; Quantin X; Reme-Saumon M; Cupissol D; Khial F; Michel FB
Chest; 1999 Jan; 115(1):144-50. PubMed ID: 9925076
[TBL] [Abstract][Full Text] [Related]
12. Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter.
Pradier O; Lederer K; Hille A; Weiss E; Christiansen H; Schmidberger H; Hess CF
J Cancer Res Clin Oncol; 2005 Apr; 131(4):261-9. PubMed ID: 15616830
[TBL] [Abstract][Full Text] [Related]
13. [Induction chemotherapy followed by concomitant combined radiotherapy and chemotherapy in stage III non-small cell bronchial carcinoma].
Bouillet T; Morère JF; Mazeron JJ; Piperno-Neuman S; Boaziz C; Haddad E; Breau JL
Cancer Radiother; 1997; 1(2):121-31. PubMed ID: 9273182
[TBL] [Abstract][Full Text] [Related]
14. Thoracic radiotherapy and daily vinorelbine as radiosensitizer in locally advanced non small cell lung cancer: a phase I study.
Gridelli C; Guida C; Barletta E; Gatani T; Fiore F; Barzelloni ML; Rossi A; de Bellis M; D'Aniello R; Scognamiglio F
Lung Cancer; 2000 Aug; 29(2):131-7. PubMed ID: 10963843
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional conformal radiation therapy for non-small-cell lung cancer: a phase I/II dose escalation clinical trial.
Wu KL; Jiang GL; Liao Y; Qian H; Wang LJ; Fu XL; Zhao S
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1336-44. PubMed ID: 14630271
[TBL] [Abstract][Full Text] [Related]
16. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
Bahri S; Flickinger JC; Kalend AM; Deutsch M; Belani CP; Sciurba FC; Luketich JD; Greenberger JS
Radiat Oncol Investig; 1999; 7(5):297-308. PubMed ID: 10580899
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancer.
Lee SW; Choi EK; Lee JS; Lee SD; Suh C; Kim SW; Kim WS; Ahn SD; Yi BY; Kim JH; Noh YJ; Kim SS; Koh Y; Kim DS; Kim WD
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):996-1004. PubMed ID: 12829135
[TBL] [Abstract][Full Text] [Related]
18. Five-year results of a phase II trial of hyperfractionated radiotherapy and concurrent daily cisplatin chemotherapy for stage III non-small-cell lung cancer.
Keene KS; Harman EM; Knauf DG; McCarley D; Zlotecki RA
Am J Clin Oncol; 2005 Jun; 28(3):217-22. PubMed ID: 15923791
[TBL] [Abstract][Full Text] [Related]
19. Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer.
Takeda K; Negoro S; Kudoh S; Okishio K; Masuda N; Takada M; Tanaka M; Nakajima T; Tada T; Fukuoka M
Br J Cancer; 1999 Mar; 79(9-10):1462-7. PubMed ID: 10188891
[TBL] [Abstract][Full Text] [Related]
20. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.
Dillman RO; Herndon J; Seagren SL; Eaton WL; Green MR
J Natl Cancer Inst; 1996 Sep; 88(17):1210-5. PubMed ID: 8780630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
